About Us
BioVentrix, Inc. is a clinical stage medical device company serving cardiothoracic surgeons and their patients with lifesaving heart failure therapies. BioVentrix technologies aim to improve cardiac function by directly addressing LV dilation.
The BioVentrix Revivent System is designed to support a less invasive procedure to treat a dilated left ventricle of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and extensive left ventricular scar, who have a suboptimal response to guideline-directed medical therapy. The procedure uses myocardial micro-anchor implants to reconstruct the dilated left ventricle to produce a more efficient chamber.
Management Team
Steven Chartier
President and Co-Chief Executive Officer
David Richmond
Co-Chief Executive Officer
Ori Ben-Yehuda, MD
Chief Medical Officer
Larry Brubach
VP, Therapy Development
Fabio Felix
Director, Manufacturing
Dan Stack
Director, Quality
Board of Directors
Steven Chartier
President and Co-Chief Executive Officer
David Richmond
Co-Chief Executive Officer
William T. Abraham
MD
Chief Medical Officer,
V-Wave Ltd., Professor of Medicine, Physiology and Cell Biology, The Ohio State University
Rishi Puri
MD, PhD, FRACP
Coronary and Structural Heart Disease Interventional Cardiologist, Cleveland Clinic
Mark R. Ravich
BSE, MBA
President, Tri-Star Management, Inc.
